| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |